EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Boolean logic in synthetic biology and biomaterials: Towards living materials in mammalian cell therapeutics

Eric M Bressler iD, Sarah Adams, Rong Liu, Yolonda L Colson, Wilson W Wong iD, Mark W Grinstaff

Clinical and Translational Medicine · 2023-07 · 13 (7)

DOI: 10.1002/ctm2.1244 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 29.06.2023. Verfasst von Eric M Bressler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Biological Design Center, Boston University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Synthetic Biology, Biocompatible Materials. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The intersection of synthetic biology and biomaterials promises to enhance safety and efficacy in novel therapeutics. Both fields increasingly employ Boolean logic, which allows for specific therapeutic outputs (e.g., drug release, peptide synthesis) in response to inputs such as disease markers or bio‐orthogonal stimuli. Examples include stimuli‐responsive drug delivery devices and logic‐gated chimeric antigen receptor (CAR) T cells. In this review, we explore recent manuscripts highlighting the potential of synthetic biology and biomaterials with Boolean logic to create novel and efficacious living therapeutics. Main body : Collaborations in synthetic biology and biomaterials have led to significant advancements in drug delivery and cell therapy. Borrowing from synthetic biology, researchers have created Boolean‐responsive biomaterials sensitive to multiple inputs including pH, light, enzymes and more to produce functional outputs such as degradation, gel‐sol transition and conformational change. Biomaterials also enhance synthetic biology, particularly CAR T and adoptive T cell therapy, by modulating therapeutic immune cells in vivo. Nanoparticles and hydrogels also enable in situ generation of CAR T cells, which promises to drive down production costs and expand access to these therapies to a larger population. Biomaterials are also used to interface with logic‐gated CAR T cell therapies, creating controllable cellular therapies that enhance safety and efficacy. Finally, designer cells acting as living therapeutic factories benefit from biomaterials that improve biocompatibility and stability in vivo.

Conclusion

By using Boolean logic in both cellular therapy and drug delivery devices, researchers have achieved better safety and efficacy outcomes. While early projects show incredible promise, coordination between these fields is ongoing and growing. We expect that these collaborations will continue to grow and realize the next generation of living biomaterial therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Synthetic BiologyBiocompatible MaterialsAnimalsCell- and Tissue-Based TherapyDrug Delivery SystemsImmunotherapy, AdoptiveMammals

Stichwörter der Autor:innen

CAR T cellsbiomaterialsboolean logiccell therapydrug deliverysynthetic biology

Substanzen

Biocompatible Materials

Autor:innen und Institutionen

  • Department of Biomedical Engineering and Biological Design Center, Boston University, Boston, Massachusetts, USA.
  • Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Chemistry and Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA.

ORCID-Profile: Eric M Bressler, Wilson W Wong

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Biomedical Imaging and Bioengineering

Zitieren

APA

Bressler, E. M., Adams, S., Liu, R., Colson, Y. L., Wong, W. W., & Grinstaff, M. W. (2023). Boolean logic in synthetic biology and biomaterials: Towards living materials in mammalian cell therapeutics. Clinical and Translational Medicine, 13(7). https://doi.org/10.1002/ctm2.1244

Vancouver

Bressler EM, Adams S, Liu R, Colson YL, Wong WW, Grinstaff MW. Boolean logic in synthetic biology and biomaterials: Towards living materials in mammalian cell therapeutics. Clinical and Translational Medicine. 2023;13(7). doi:10.1002/ctm2.1244

BibTeX
@article{Bressler2023,
  author = {Bressler, Eric M and Adams, Sarah and Liu, Rong and Colson, Yolonda L and Wong, Wilson W and Grinstaff, Mark W},
  title = {Boolean logic in synthetic biology and biomaterials: Towards living materials in mammalian cell therapeutics},
  journal = {Clinical and Translational Medicine},
  year = {2023},
  volume = {13},
  number = {7},
  doi = {10.1002/ctm2.1244}
}
Kostenlos starten →